Search - tctmd.com

Displaying 701 - 720 of 844

Sort: Relevancy | Date

News Daily News

Polyvascular Disease Worsens Long-term Prognosis for Older NSTEMI Patients

July 03, 2012

News Daily News

Better Strategies for Diagnostic Imaging Can Cut Unnecessary Treatment for CAD

Yael L. Maxwell

June 29, 2012

News Industry News

OrbusNeich's Genous™ Stent Is Safe and Effective in Patients Who Discontinue Dual Antiplatelet Therapy (DAPT) Within 15 Days of Stent Placement

June 21, 2012

News Daily News

CTA Not Justified to Risk Stratify Patients Without Chest Pain

L.A. McKeown

June 18, 2012

News Daily News

VA Registry Finds Long-term Benefit from Clopidogrel Beyond 12 Months

Caitlin E. Cox

June 11, 2012

News Daily News

Antianginal Drug May Reduce Periprocedural MI in Elective PCI

Yael L. Maxwell

June 08, 2012

News Industry News

Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element™ Plus Platinum Chromium Stent System

June 04, 2012

News Industry News

Medtronic Resolute® Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes

May 25, 2012

News Conference News EuroPCR 2012

Radial Approach Paving the Way to Better Outcomes in Acute MI Patients

Jason Kahn

May 18, 2012

News Industry News

PROMUS Element™ Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study

May 18, 2012

News Industry News

Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries

May 16, 2012

News Industry News

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent

May 15, 2012

News Industry News

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

May 15, 2012

News Conference News EuroPCR 2012

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Jason Kahn

May 15, 2012

News Industry News

Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy

May 15, 2012

News Daily News

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

May 09, 2012

News Industry News

OrbusNeich’s Combo Dual Therapy Stent™ Featured During Symposium at Angioplasty Summit TCTAP 2012

April 25, 2012

News Daily News

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

L.A. McKeown

April 25, 2012

News Daily News

Meta Análisis: Los SLF de 1ª Generación se Muestran Seguros y Eficaces a Largo Plazo contra los STEMI

L.A. McKeown

April 25, 2012

News Daily News

Incomplete Revascularization Puts Diabetics at Increased Risk of Long-term Events

Leah Lawrence

April 20, 2012

Advertisement

Polyvascular Disease Worsens Long-term Prognosis for Older NSTEMI Patients

Better Strategies for Diagnostic Imaging Can Cut Unnecessary Treatment for CAD

OrbusNeich's Genous™ Stent Is Safe and Effective in Patients Who Discontinue Dual Antiplatelet Therapy (DAPT) Within 15 Days of Stent Placement

CTA Not Justified to Risk Stratify Patients Without Chest Pain

VA Registry Finds Long-term Benefit from Clopidogrel Beyond 12 Months

Antianginal Drug May Reduce Periprocedural MI in Elective PCI

Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element™ Plus Platinum Chromium Stent System

Medtronic Resolute® Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes

Radial Approach Paving the Way to Better Outcomes in Acute MI Patients

PROMUS Element™ Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study

Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

OrbusNeich’s Combo Dual Therapy Stent™ Featured During Symposium at Angioplasty Summit TCTAP 2012

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

Meta Análisis: Los SLF de 1ª Generación se Muestran Seguros y Eficaces a Largo Plazo contra los STEMI

Incomplete Revascularization Puts Diabetics at Increased Risk of Long-term Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content